All In Biotech

Drug Trial Radar · NCT00070733

The Effect of 5-Alpha Reductase on Testosterone in Men

The Role of 5-Alpha Reductase in Mediating Testosterone Actions

Last checked: Nov 20, 2026Latest source record: Nov 7, 2005 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknownPivotal-lookingPhase 3. Randomized with 184 participants. This is a heuristic, not a regulatory label.

Status

Status unknown

Enrollment

184

Actual

Start

Aug 2003

Primary completion

Not stated

Study completion Jun 2005

Sponsor

Sponsor type
NIH
First posted
Oct 10, 2003

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double
Primary purpose
Treatment
Who can join
Male only, from 21 years, up to 40 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The enzyme 5-alpha reductase is present in small amounts in muscle and converts testosterone to dihydrotestosterone (DHT). Testosterone affects lean body tissue, muscle size, muscle strength, and sexual function in men. This study will evaluate how 5-alpha reductase influences the effects of testosterone in young healthy men.

Conditions

  • Sex Disorders

Interventions

  • testosterone enanthateDrug

  • duastrideDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

No primary outcomes listed.

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Charles R. Drew University

    Los Angeles, California · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.